{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T12:37:36Z","timestamp":1782218256631,"version":"3.54.5"},"reference-count":97,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.ejmech.2021.113527","type":"journal-article","created":{"date-parts":[[2021,5,8]],"date-time":"2021-05-08T19:49:06Z","timestamp":1620503346000},"page":"113527","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Dengue structural proteins as antiviral drug targets: Current status in the drug discovery &amp; development"],"prefix":"10.1016","volume":"221","author":[{"given":"Akshatha H.","family":"S","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0658-3636","authenticated-orcid":false,"given":"Gurubasavaraj V.","family":"Pujar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun Kumar","family":"Sethu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meduri","family":"Bhagyalalitha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ejmech.2021.113527_bib1","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/nri3916","article-title":"New insights into the immunopathology and control of dengue virus infection","volume":"15","author":"Screaton","year":"2015","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.ejmech.2021.113527_bib2","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1146\/annurev-virology-110615-042334","article-title":"Properties and functions of the dengue virus capsid protein","volume":"3","author":"Byk","year":"2017","journal-title":"Annu. Rev. Virol."},{"key":"10.1016\/j.ejmech.2021.113527_bib3","first-page":"101","article-title":"A\u00a0putative fifth serotype of dengue-potential implications for diagnosis, therapy and vaccine design","volume":"1","author":"Taylor-Robinson Andrew","year":"2016","journal-title":"Int. J. Clin. Med. Microbiol."},{"issue":"1","key":"10.1016\/j.ejmech.2021.113527_bib4","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.mjafi.2014.09.011","article-title":"Discovery of fifth serotype of dengue virus (Denv-5): a new public Health dilemma in dengue control","volume":"71","author":"Mustafa","year":"2015","journal-title":"Med. J. Armed Forces India"},{"key":"10.1016\/j.ejmech.2021.113527_bib5","article-title":"Trends of dengue disease epidemiology","volume":"8","author":"Cucunawangsih","year":"2017","journal-title":"Virol. Res. Treat."},{"issue":"March","key":"10.1016\/j.ejmech.2021.113527_bib6","first-page":"1","article-title":"Dengue and severe dengue","volume":"117","year":"2014","journal-title":"WHO Fact Sheet"},{"key":"10.1016\/j.ejmech.2021.113527_bib7","series-title":"Dengue Vaccines","first-page":"4","author":"World Health Organization","year":"2018"},{"key":"10.1016\/j.ejmech.2021.113527_bib8","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1016\/S0140-6736(19)32525-5","article-title":"Vaccine-attributable severe dengue in the Philippines","volume":"14","author":"Wilder-Smith","year":"2019","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ejmech.2021.113527_bib9","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0092-8674(02)00660-8","article-title":"Structure of dengue virus: implications for Flavivirus organization, maturation, and fusion","volume":"108","author":"Kuhn","year":"2002","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.ejmech.2021.113527_bib10","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-65625-6","article-title":"Dengue virus capsid protein dynamics reveals spatially heterogeneous motion in live-infected-cells","volume":"10","author":"Gabriel","year":"2020","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.ejmech.2021.113527_bib11","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1128\/JVI.06796-11","article-title":"Dengue virus capsid protein binding to hepatic lipid droplets (LD) is potassium ion dependent and is mediated by LD surface proteins","volume":"86","author":"Carvalho","year":"2012","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ejmech.2021.113527_bib12","article-title":"Dengue virus and the host innate immune response","volume":"1","author":"Uno","year":"2018","journal-title":"Emerg. Microbes Infect."},{"issue":"24","key":"10.1016\/j.ejmech.2021.113527_bib13","doi-asserted-by":"crossref","first-page":"13094","DOI":"10.1128\/JVI.00704-13","article-title":"Nucleolin interacts with the dengue virus capsid protein and plays a role in formation of infectious virus particles","volume":"87","author":"Balinsky","year":"2013","journal-title":"J.\u00a0Virol."},{"issue":"1","key":"10.1016\/j.ejmech.2021.113527_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-39185-3","article-title":"Mutations in the dimer interfaces of the dengue virus capsid protein affect structural stability and impair RNA-capsid interaction","volume":"9","author":"Figueira-Mansur","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2021.113527_bib15","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1016\/j.ddmec.2011.09.001","article-title":"Platelets in dengue infection","author":"Hottz","year":"2011","journal-title":"Drug Discov. Today Dis. Mech."},{"issue":"17","key":"10.1016\/j.ejmech.2021.113527_bib16","doi-asserted-by":"crossref","first-page":"6795","DOI":"10.1073\/pnas.1304300110","article-title":"Dengue structure differs at the temperatures of its human and mosquito hosts","volume":"110","author":"Zhang","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"23","key":"10.1016\/j.ejmech.2021.113527_bib17","doi-asserted-by":"crossref","first-page":"11418","DOI":"10.1128\/JVI.01257-06","article-title":"Recent advances in deciphering viral and host determinants of dengue virus replication and pathogenesis","volume":"80","author":"Clyde","year":"2006","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ejmech.2021.113527_bib18","series-title":"FEMS Microbiology Reviews","first-page":"155","article-title":"Receptors and routes of dengue virus entry into the host cells","author":"Cruz-Oliveira","year":"2015"},{"key":"10.1016\/j.ejmech.2021.113527_bib19","first-page":"1","article-title":"Roles of macrophage migration inhibitory factor in dengue pathogenesis: from pathogenic factor to therapeutic target","volume":"1","author":"Lai","year":"2020","journal-title":"Microorganisms"},{"issue":"13","key":"10.1016\/j.ejmech.2021.113527_bib20","doi-asserted-by":"crossref","first-page":"7136","DOI":"10.1128\/JVI.00116-07","article-title":"Essential role of dengue virus envelope protein N glycosylation at asparagine-67 during viral propagation","volume":"81","author":"Mondotte","year":"2007","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ejmech.2021.113527_bib21","doi-asserted-by":"crossref","first-page":"575","DOI":"10.2217\/fvl.10.49","article-title":"Insights into dengue virus Genome\u00c2 replication","author":"Alcaraz-Estrada","year":"2010","journal-title":"Future Virol."},{"key":"10.1016\/j.ejmech.2021.113527_bib22","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.mib.2008.06.004","article-title":"Structural proteomics of dengue virus","author":"Perera","year":"2008","journal-title":"Curr. Opin. Microbiol."},{"issue":"8","key":"10.1016\/j.ejmech.2021.113527_bib23","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.chembiol.2018.05.011","article-title":"Inhibition of flaviviruses by targeting a conserved pocket on the viral envelope protein","volume":"25","author":"de Wispelaere","year":"2018","journal-title":"Cell Chem. Biol."},{"issue":"3","key":"10.1016\/j.ejmech.2021.113527_bib24","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1021\/acsinfecdis.8b00322","article-title":"Small Molecules Targeting the Flavivirus e Protein with Broad-Spectrum Activity and Antiviral Efficacy in\u00a0Vivo","volume":"5","author":"Li","year":"2019","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2021.113527_bib25","series-title":"Applied Microbiology and Biotechnology","first-page":"2977","article-title":"Dengue viruses and promising envelope protein domain III-based vaccines","author":"Fahimi","year":"2018"},{"issue":"1","key":"10.1016\/j.ejmech.2021.113527_bib26","doi-asserted-by":"crossref","DOI":"10.1186\/s12985-018-0970-2","article-title":"Dengue virus-like particles mimic the antigenic properties of the infectious dengue virus envelope","volume":"15","author":"Metz","year":"2018","journal-title":"Virol. J."},{"issue":"6243","key":"10.1016\/j.ejmech.2021.113527_bib27","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1126\/science.aaa8651","article-title":"Cryo-EM structure of an antibody that neutralizes dengue virus type 2 by locking E protein dimers","volume":"349","author":"Fibriansah","year":"2015","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.ejmech.2021.113527_bib28","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.cell.2005.11.042","article-title":"Cryo-EM reconstruction of dengue virus in complex with the carbohydrate recognition domain of DC-SIGN","volume":"124","author":"Pokidysheva","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2021.113527_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms7341","article-title":"A\u00a0highly potent human antibody neutralizes dengue virus serotype 3 by binding across three surface proteins","volume":"6","author":"Fibriansah","year":"2015","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.ejmech.2021.113527_bib30","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1128\/JVI.02957-12","article-title":"Structure of a dengue virus envelope protein late-stage fusion intermediate","volume":"87","author":"Klein","year":"2013","journal-title":"J.\u00a0Virol."},{"issue":"46","key":"10.1016\/j.ejmech.2021.113527_bib31","doi-asserted-by":"crossref","first-page":"18662","DOI":"10.1073\/pnas.1310962110","article-title":"Atomic-level functional model of dengue virus envelope protein infectivity","volume":"110","author":"Christian","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"6972","key":"10.1016\/j.ejmech.2021.113527_bib32","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nature02165","article-title":"Structure of the dengue virus envelope protein after membrane fusion","volume":"427","author":"Modis","year":"2004","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.ejmech.2021.113527_bib33","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1128\/JVI.05431-11","article-title":"Uncoupling cis-acting RNA elements from coding sequences revealed a requirement of the N-terminal region of dengue virus capsid protein in virus particle formation","volume":"86","author":"Samsa","year":"2012","journal-title":"J.\u00a0Virol."},{"issue":"16","key":"10.1016\/j.ejmech.2021.113527_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20163870","article-title":"Structural and functional properties of the capsid protein of dengue and related Flavivirus","volume":"20","author":"Faustino","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.ejmech.2021.113527_bib35","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1073\/pnas.0305892101","article-title":"Solution structure of dengue virus capsid protein reveals another fold","volume":"101","author":"Ma","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.ejmech.2021.113527_bib36","article-title":"Understanding Flavivirus capsid protein functions: the tip of the iceberg","volume":"1","author":"Sotcheff","year":"2020","journal-title":"Pathogens"},{"issue":"3","key":"10.1016\/j.ejmech.2021.113527_bib37","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00804-16","article-title":"Dengue virus genome uncoating requires ubiquitination","volume":"7","author":"Byk","year":"2016","journal-title":"mBio"},{"key":"10.1016\/j.ejmech.2021.113527_bib38","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.virol.2016.12.013","article-title":"Kinetics of the association of dengue virus capsid protein with the granular component of nucleolus","volume":"502","author":"Tiwary","year":"2017","journal-title":"Virology"},{"issue":"7","key":"10.1016\/j.ejmech.2021.113527_bib39","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.febslet.2012.02.047","article-title":"The dengue virus M protein localises to the endoplasmic reticulum and forms oligomers","volume":"586","author":"Wong","year":"2012","journal-title":"FEBS Lett."},{"issue":"48","key":"10.1016\/j.ejmech.2021.113527_bib40","doi-asserted-by":"crossref","first-page":"40525","DOI":"10.1074\/jbc.M112.384446","article-title":"The stem region of premembrane protein plays an important role in the virus surface protein rearrangement during dengue maturation","volume":"287","author":"Zhang","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"issue":"5871","key":"10.1016\/j.ejmech.2021.113527_bib41","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1126\/science.1153263","article-title":"The Flavivirus precursor membrane-envelope protein complex: structure and maturation","volume":"319","author":"Li","year":"2008","journal-title":"Science"},{"issue":"48","key":"10.1016\/j.ejmech.2021.113527_bib42","doi-asserted-by":"crossref","first-page":"33149","DOI":"10.1074\/jbc.M114.610428","article-title":"Highly conserved residues in the helical domain of dengue virus type 1 precursor membrane protein are involved in assembly, precursor membrane (PrM) protein cleavage, and entry","volume":"289","author":"Hsieh","year":"2014","journal-title":"J.\u00a0Biol. Chem."},{"issue":"11","key":"10.1016\/j.ejmech.2021.113527_bib43","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/nsb990","article-title":"Visualization of membrane protein domains by cryo-electron microscopy of dengue virus","volume":"10","author":"Zhang","year":"2003","journal-title":"Nat. Struct. Biol."},{"issue":"1","key":"10.1016\/j.ejmech.2021.113527_bib44","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.virol.2010.11.006","article-title":"The C-terminal helical domain of dengue virus precursor membrane protein is involved in virus assembly and entry","volume":"410","author":"Hsieh","year":"2011","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.ejmech.2021.113527_bib45","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1099\/vir.0.035964-0","article-title":"A\u00a0conserved region in the PrM protein is a critical determinant in the assembly of Flavivirus particles","volume":"93","author":"Yoshii","year":"2012","journal-title":"J.\u00a0Gen. Virol."},{"issue":"16","key":"10.1016\/j.ejmech.2021.113527_bib46","doi-asserted-by":"crossref","first-page":"8353","DOI":"10.1128\/JVI.00696-10","article-title":"Influence of Pr-M cleavage on the heterogeneity of extracellular dengue virus particles","volume":"84","author":"Junjhon","year":"2010","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ejmech.2021.113527_bib47","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.tips.2013.11.006","article-title":"Current progress in antiviral strategies","author":"Lou","year":"2014","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2021.113527_bib48","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1002\/med.21664","article-title":"Medicinal chemistry strategies toward host targeting antiviral agents","author":"Ji","year":"2020","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2021.113527_bib49","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.coviro.2012.09.001","article-title":"New horizons for antiviral drug discovery from virus-host protein interaction networks","author":"De Chassey","year":"2012","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.ejmech.2021.113527_bib50","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.coviro.2020.07.009","article-title":"Recent advances in antiviral drug development towards dengue virus","volume":"1","author":"Troost","year":"2020","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.ejmech.2021.113527_bib51","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10989-016-9534-8","article-title":"Peptides as \u2018drugs\u2019: the journey so far","author":"Sachdeva","year":"2017","journal-title":"Int. J. Pept. Res. Therapeut."},{"key":"10.1016\/j.ejmech.2021.113527_bib52","author":"Pytlik"},{"issue":"6","key":"10.1016\/j.ejmech.2021.113527_bib53","doi-asserted-by":"crossref","first-page":"728","DOI":"10.3390\/ph6060728","article-title":"Database-guided discovery of potent peptides to combat HIV-1 or superbugs","volume":"6","author":"Wang","year":"2013","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2021.113527_bib54","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.drudis.2009.10.009","article-title":"Synthetic therapeutic peptides: science and market","author":"Vlieghe","year":"2010","journal-title":"Drug Discov. Today"},{"issue":"2","key":"10.1016\/j.ejmech.2021.113527_bib55","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1021\/cb500640t","article-title":"Understanding dengue virus capsid protein disordered N-terminus and pep14-23-based inhibition","volume":"10","author":"Faustino","year":"2015","journal-title":"ACS Chem. Biol."},{"issue":"8","key":"10.1016\/j.ejmech.2021.113527_bib56","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/abbs\/36.8.577","article-title":"Development of cell lines stably expressing staphylococcal nuclease fused to dengue 2 virus capsid protein for CTVI","volume":"36","author":"Qin","year":"2004","journal-title":"Acta Biochim. Biophys. Sin."},{"issue":"4","key":"10.1016\/j.ejmech.2021.113527_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.ppat.1000851","article-title":"Peptide inhibitors of dengue-virus entry target a late- stage fusion intermediate","volume":"6","author":"Schmidt","year":"2010","journal-title":"PLoS Pathog."},{"issue":"1","key":"10.1016\/j.ejmech.2021.113527_bib58","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1743-422X-2-49","article-title":"Peptide inhibitors of dengue virus and west nile virus infectivity","volume":"2","author":"Hrobowski","year":"2005","journal-title":"Virol. J."},{"issue":"6","key":"10.1016\/j.ejmech.2021.113527_bib59","doi-asserted-by":"crossref","first-page":"e721","DOI":"10.1371\/journal.pntd.0000721","article-title":"Structural optimization and de novo design of dengue virus entry inhibitory peptides","volume":"4","author":"Costin","year":"2010","journal-title":"PLoS Neglected Trop. Dis."},{"issue":"1","key":"10.1016\/j.ejmech.2021.113527_bib60","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10867-018-9515-6","article-title":"Dynamics and binding interactions of peptide inhibitors of dengue virus entry","volume":"45","author":"Isa","year":"2019","journal-title":"J.\u00a0Biol. Phys."},{"issue":"5","key":"10.1016\/j.ejmech.2021.113527_bib61","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1111\/cbdd.12576","article-title":"A\u00a0peptide inhibitor derived from the conserved ectodomain region of DENV membrane (M) protein with activity against dengue virus infection","volume":"86","author":"Panya","year":"2015","journal-title":"Chem. Biol. Drug Des."},{"issue":"1","key":"10.1016\/j.ejmech.2021.113527_bib62","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/cbdd.12055","article-title":"The future of peptide-based drugs","volume":"81","author":"Craik","year":"2013","journal-title":"Chem. Biol. Drug Des."},{"issue":"1","key":"10.1016\/j.ejmech.2021.113527_bib63","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1128\/AAC.01429-12","article-title":"A\u00a0novel inhibitor of dengue virus replication that targets the capsid protein","volume":"57","author":"Byrd","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2021.113527_bib64","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.antiviral.2018.04.019","article-title":"Characterization and structure-activity relationship analysis of a class of antiviral compounds that directly bind dengue virus capsid protein and are incorporated into virions","volume":"155","author":"Smith","year":"2018","journal-title":"Antivir. Res."},{"issue":"4","key":"10.1016\/j.ejmech.2021.113527_bib65","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002627","article-title":"Small-molecule inhibitors of dengue-virus entry","volume":"8","author":"Schmidt","year":"2012","journal-title":"PLoS Pathog."},{"issue":"2","key":"10.1016\/j.ejmech.2021.113527_bib66","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.antiviral.2010.09.002","article-title":"Antiviral activity of chondroitin sulphate E targeting dengue virus envelope protein","volume":"88","author":"Kato","year":"2010","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2021.113527_bib67","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/8648956","article-title":"Anti-dengue, cytotoxicity, antifungal, and in silico study of the newly synthesized 3-O-Phospo-\u03b1-D-Glucopyranuronic acid compound","volume":"2018","author":"Abu-Izneid","year":"2018","journal-title":"BioMed Res. Int."},{"issue":"1","key":"10.1016\/j.ejmech.2021.113527_bib68","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0166-3542(02)00095-5","article-title":"Heparin inhibits dengue-2 virus infection of five human liver cell lines","volume":"56","author":"Lin","year":"2002","journal-title":"Antivir. Res."},{"issue":"1","key":"10.1016\/j.ejmech.2021.113527_bib69","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.antiviral.2005.08.006","article-title":"Antiviral effect of the heparan sulfate mimetic, PI-88, against dengue and encephalitic flaviviruses","volume":"69","author":"Lee","year":"2006","journal-title":"Antivir. Res."},{"issue":"3","key":"10.1016\/j.ejmech.2021.113527_bib70","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.bbrc.2012.07.002","article-title":"3-O-Sulfated glucuronide derivative as a potential anti-dengue virus agent","volume":"424","author":"Hidari","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.ejmech.2021.113527_bib71","doi-asserted-by":"crossref","first-page":"e428","DOI":"10.1371\/journal.pone.0000428","article-title":"Combinatorial computational approaches to identify tetracycline derivatives as Flavivirus inhibitors","volume":"2","author":"Yang","year":"2007","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ejmech.2021.113527_bib72","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.antiviral.2009.09.011","article-title":"A\u00a0small molecule fusion inhibitor of dengue virus","volume":"84","author":"Poh","year":"2009","journal-title":"Antivir. Res."},{"issue":"12","key":"10.1016\/j.ejmech.2021.113527_bib73","doi-asserted-by":"crossref","first-page":"5269","DOI":"10.1128\/AAC.00686-10","article-title":"A\u00a0derivate of the antibiotic doxorubicin is a selective inhibitor of dengue and yellow fever virus replication in\u00a0vitro","volume":"54","author":"Kaptein","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.ejmech.2021.113527_bib74","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1371\/journal.pntd.0002188","article-title":"Sulfated polysaccharide, curdlan sulfate, efficiently prevents entry\/fusion and restricts antibody-dependent enhancement of dengue virus infection in\u00a0vitro: a possible candidate for clinical application","volume":"7","author":"Ichiyama","year":"2013","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ejmech.2021.113527_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111628","article-title":"De novo design approaches targeting an envelope protein pocket to identify small molecules against dengue virus","volume":"182","author":"Leal","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"10.1016\/j.ejmech.2021.113527_bib76","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1128\/AAC.01148-08","article-title":"A\u00a0small-molecule dengue virus entry inhibitor","volume":"53","author":"Wang","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"issue":"12","key":"10.1016\/j.ejmech.2021.113527_bib77","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1021\/cb800176t","article-title":"Antiviral compounds discovered by virtual screening of small-molecule libraries against dengue virus E protein","volume":"3","author":"Zhou","year":"2008","journal-title":"ACS Chem. Biol."},{"issue":"6","key":"10.1016\/j.ejmech.2021.113527_bib78","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021658","article-title":"Broad antiviral activity of carbohydrate-binding agents against the four serotypes of dengue virus in monocyte-derived dendritic cells","volume":"6","author":"Alen","year":"2011","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.ejmech.2021.113527_bib79","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0074035","article-title":"Sulfated Escherichia coli K5 polysaccharide derivatives inhibit dengue virus infection of human microvascular endothelial cells by interacting with the viral envelope protein E domain III","volume":"8","author":"Vervaeke","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2021.113527_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2019.104636","article-title":"A\u00a0novel Flavivirus entry inhibitor, BP34610, discovered through high-throughput screening with dengue reporter viruses","volume":"172","author":"Yang","year":"2019","journal-title":"Antivir. Res."},{"issue":"3","key":"10.1016\/j.ejmech.2021.113527_bib81","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.antiviral.2009.09.007","article-title":"In silico screening of small molecule libraries using the dengue virus envelope E protein has identified compounds with antiviral activity against multiple flaviviruses","volume":"84","author":"Kampmann","year":"2009","journal-title":"Antivir. Res."},{"issue":"2","key":"10.1016\/j.ejmech.2021.113527_bib82","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.antiviral.2008.05.007","article-title":"In\u00a0vitro inhibition of dengue virus entry by P-Sulfoxy-Cinnamic acid and structurally related combinatorial chemistries","volume":"80","author":"Rees","year":"2008","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2021.113527_bib83","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4137\/DTI.S31566","article-title":"Screening analogs of \u03b2-OG pocket binder as fusion inhibitor of dengue virus 2","volume":"9","author":"Tambunan","year":"2015","journal-title":"Drug Target Insights"},{"issue":"12","key":"10.1016\/j.ejmech.2021.113527_bib84","doi-asserted-by":"crossref","first-page":"6986","DOI":"10.1073\/pnas.0832193100","article-title":"A\u00a0ligand-binding pocket in the dengue virus envelope glycoprotein","volume":"100","author":"Modis","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"7","key":"10.1016\/j.ejmech.2021.113527_bib85","doi-asserted-by":"crossref","first-page":"840","DOI":"10.2174\/1570180816666191105124535","article-title":"Development of novel glitazones as antidiabetic agents: molecular design, synthesis, evaluation of glucose uptake activity and SAR studies","volume":"17","author":"Srinivas","year":"2019","journal-title":"Lett. Drug Des. Discov."},{"key":"10.1016\/j.ejmech.2021.113527_bib86","series-title":"Biochemistry, Glycosaminoglycans","author":"Casale","year":"2019"},{"issue":"1","key":"10.1016\/j.ejmech.2021.113527_bib87","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/s12985-017-0895-1","article-title":"Geraniin extracted from the rind of Nephelium lappaceum binds to dengue virus type-2 envelope protein and inhibits early stage of virus replication","volume":"14","author":"Abdul Ahmad","year":"2017","journal-title":"Virol. J."},{"issue":"1","key":"10.1016\/j.ejmech.2021.113527_bib88","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.bbrc.2008.08.100","article-title":"Structure and anti-dengue virus activity of sulfated polysaccharide from a marine alga","volume":"376","author":"Hidari","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.ejmech.2021.113527_bib89","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.virol.2007.01.043","article-title":"Interference in dengue virus adsorption and uncoating by carrageenans","volume":"363","author":"Talarico","year":"2007","journal-title":"Virology"},{"issue":"11","key":"10.1016\/j.ejmech.2021.113527_bib90","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112351","article-title":"Phospholipase A2 isolated from the venom of Crotalus durissus terrificus inactivates dengue virus and other enveloped viruses by disrupting the viral envelope","volume":"9","author":"Muller","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ejmech.2021.113527_bib91","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0166-3542(03)00175-X","article-title":"In\u00a0vitro and in\u00a0vivo antiviral properties of sulfated galactomannans against yellow fever virus (BeH111 strain) and dengue 1 virus (Hawaii strain)","volume":"60","author":"Ono","year":"2003","journal-title":"Antivir. Res."},{"issue":"4","key":"10.1016\/j.ejmech.2021.113527_bib92","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.ijbiomac.2012.05.028","article-title":"Antiviral activity against dengue virus of diverse classes of algal sulfated polysaccharides","volume":"51","author":"Pujol","year":"2012","journal-title":"Int. J. Biol. Macromol."},{"issue":"2\u20133","key":"10.1016\/j.ejmech.2021.113527_bib93","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.antiviral.2005.02.001","article-title":"The antiviral activity of sulfated polysaccharides against dengue virus is dependent on virus serotype and host cell","volume":"66","author":"Talarico","year":"2005","journal-title":"Antivir. Res."},{"issue":"1","key":"10.1016\/j.ejmech.2021.113527_bib94","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2180-13-187","article-title":"Broad-spectrum antiviral activity of chebulagic acid and punicalagin against viruses that use glycosaminoglycans for entry","volume":"13","author":"Lin","year":"2013","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.ejmech.2021.113527_bib95","doi-asserted-by":"crossref","first-page":"683","DOI":"10.4155\/cli.14.67","article-title":"The challenges of dengue drug discovery and development","volume":"8","author":"Gu","year":"2014","journal-title":"Clin. Invest."},{"key":"10.1016\/j.ejmech.2021.113527_bib96","author":"Canard"},{"key":"10.1016\/j.ejmech.2021.113527_bib97","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.antiviral.2018.12.016","article-title":"Dengue drug discovery: progress, challenges and outlook","author":"Lim","year":"2019","journal-title":"Antivir. Res."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421003767?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421003767?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:29:56Z","timestamp":1759328996000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523421003767"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":97,"alternative-id":["S0223523421003767"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113527","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dengue structural proteins as antiviral drug targets: Current status in the drug discovery & development","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113527","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113527"}}